ArticleScientific reports2026
Automated detection of fetal vascular malperfusion via data augmentation and algorithm improvement.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Fetal vascular malperfusion (FVM) is an important pathological factor leading to adverse pregnancy outcomes, but current manual diagnosis faces challenges such as high subjectivity and low efficiency. To address these problems, this paper proposes a joint analysis strategy based on data augmentation and deep learning model improvement. Using MONAI-based data augmentation it increases the number of FVM histopathology images while embedding a LocalWindow attention mechanism to enhance the YOLOv11 model. The experimental results show that this synergistic strategy of data augmentation and model improvement yields optimal recognition performance, with the F1 score, mAP50, and mAP50-95 increased by 7.84%, 6.53%, and 6.63%, respectively, compared with the YOLOv11 baseline model. This study indicates that a strategy combining data augmentation with model structural improvement can effectively enhance detection performance for FVM and provides a useful reference for the development of intelligent diagnostic tools for FVM in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.